Make some medications more affordable by cutting one piece of red tape
Congress is being urged to pass the Biosimilar Red Tape Elimination Act to reduce medication costs by removing the costly interchangeability standard for biologics.
We haven't written up this one. The Hill has the full story — the link below goes straight to it.
